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Abstract 
Moringa oleifera is a medicinal plant that has been used traditionally for the treatment of a number of 
ailments.  The haematological and biochemical changes following treatment of alloxan-induced 
diabetic dogs with aqueous extract of M. oleifera leaves was investigated in this study. Fifteen dogs 
with mean weight of 10 ± 1.3 kg) were divided into three equal groups. Group A were neither induced 
nor treated. Group B were induced but, untreated. Groups C were induced and treated with Moringa 
extract 5.2% (300mg/kg) orally in water, once daily, for 42 days post induction. Blood was collected 
from all dogs pre-induction, post-induction and post-treatment for haematological and biochemical 
analysis. Values obtained were expressed as mean ± standard error of means and data were analysed 
by one way Analysis of Variance (ANOVA) and Bonferroni's Multiple Comparison Test using Graph 
Pad. Fasting blood glucose (FBG) of group C decreased significantly (P < 0.05) post treatment 
compared to group B. The Packed Cell Volume, red blood cell count and haemoglobin concentration 
insignificantly (P < 0.05) decreased in diabetic groups post-induction and post-treatment, while white 
blood cells count increased. Platelet count increased post-induction and post-treatment. There was a 
significant increase (P < 0.05) in creatinine, urea, alanine aminotransferase and aspartate 
aminotransferase levels in diabetic groups compared to non-diabetic group post-induction and then 
decreased in group C post-treatment with moringa extract. Albumin and total protein concentrations 
increased significantly (P < 0.05) post-induction in diabetic groups but, decreased in group C post-
treatment. In conclusion, diabetes caused decrease in haematological parameters, and increased 
platelet count and some biochemical parameters, while moringa extract decreased biochemical 
parameters in dogs.  
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1. Introduction 
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose 
concentration caused by insulin deficiency, often combined with insulin resistance (Jelodar et 
al., 2007). It is an endocrine disease in origin, but its major manifestations are those of a 
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metabolic disturbance. Diabetes is caused by the impairment of insulin signalling pathways, 
and the defect usually results from pancreatic β-cell deficiency and/or a deficiency of insulin 
(Kahn, 1994). It is associated with an increased risk of thrombotic, atherosclerotic and 
cardiovascular disorders (DeFronzo and Ferrannini, 1991). Diabetes is characterized by 
increased thirst, polyuria, dehydration, pruritus, and unexplained weight loss (Birchard 
and Sherding, 2006). Hyperglycemia, the primary clinical manifestation of diabetes, is 
thought to contribute to diabetic complications by altering vascular cellular metabolism, 
vascular matrix molecules and circulating lipoproteins, (Chattopadhyay et al., 2005). 
Some conditions like breed (Cocker Spaniel, Beagle, Poodles, Keeshounds, 
Cairn Terrier, Dachshund, Schnauzer), female gender, obesity and age of five to seven 
years predispose dogs to hyperglycemia. The incidence of diabetes in the different breeds of 
dogs differs widely, suggesting that there may be some important genetic factors in its aetiology 
(Fall et al., 2007). In human also, the major risk factors are overweight, age more than 45 
years, higher High Density Lipoprotein(HDL) level, high blood pressure, history of 
gestational diabetes and impaired glucose tolerance, race/ethnicity (Susman, 2010). 
Diabetes due to insulin deficiency is considered to be caused by the autoimmune 
destruction of insulin-producing β-cells, pancreatitis or islet hypoplasia (Cook et al., 
1993). Treatment of the cause of insulin resistance in the dog may result in the 
remission of the condition. However, untreated cases lead to insulin deficiency because 
chronic hyperglycaemia induces permanent β-cell dysfunction (Catchpole et al., 2005). 
Despite the presence of different types of anti-diabetic drugs in the pharmaceutical market, 
diabetes with related complications continues to be a major medical problem all over the world 
(Hussein, et al., 2006). 
Interest in medicinal plants as a re-emerging health aid in the maintenance of personal health 
and well-being has been fuelled by the bio-prospecting of new plant-derived drugs (Ayo, 2010). 
Moringa oleifera is one of such medicinal plants and has been used traditionally for the treatment of a 
number of ailments including fomentation to relieve spasm, diarrhoea, as diuretic and stimulant in 
paralytic affliction, epilepsy and hysteria (Anwar et al., 2007; Paliwal et al., 2011). It has also been 
used in the treatment of ascites, rheumatism (Anwar et al., 2007) and as cardiac and circulatory 
stimulants (Limaye et al., 1995). The extract of the leaves of Moringa oleifera has been found to lower 
fasting blood glucose of streptozocin-induced diabetic wistar rats (Tende et al., 2011). ). Chemical 
constituents of the crude aqueous extract of the fresh leaves of Moringa oleifera were found to be 
tannins, saponins, carbohydrates, flavonoids, cardiac glycosides, alkaloids, steroids and terpenes while 
the crude aqueous extract of the dried leaves contain the same chemical components except for the 
absence of steroids and terpenes (Kwaghe and Ambali, 2009). This study investigated the 
haematological and biochemical changes in alloxan-induced diabetic dogs treated with aqueous extract 
of moringa leaves.  
2. MATERIALS AND METHODS 
2.1 Experimental animals 
Fifteen Nigerian indigenous dogs of both sexes with mean body weight of 10 ± 1.30kg were used for 
this work. They were kept in wooden cages and allowed to acclimatize for three weeks during which 
they were treated against some haemoparasites, using 5% oxytetracycline (Tetranor 5.5R, Jubaili 
Agrotec, China) intra-venously at the dose of 10mg/kg. They were also treated for endo- and ecto-
parasites using albendazole (ZolatR, Emzor Pharmaceutical Ind. Ltd., Lagos, Nigeria) per os at the 
dose of 7mg/kg and Fipronil (Frontline-plus®, Merial) spray, respectively. The dogs were fed twice 
daily with cooked rice and fish, and water was provided ad libitum.    
 
Journal of Medicine, Physiology and Biophysics                                                                                                                              www.iiste.org 
ISSN 2422-8427     An International Peer-reviewed Journal 
Vol.33, 2017 
 
30 
2.2 Aqueous extraction of Moringa oleifera 
The Moringa oleifera leaves were air-dried indoor and then ground into fine powder. Eight hundred 
grammes (800g) of the powder was soaked in 1000ml of distilled water at room temperature for 24 h. 
It was then filtered using Wartmann filter paper (size no. 1). The filtrate was evaporated to dryness in 
a water bath at 600C within seven hours. A brownish residue weighing 51.6 g was obtained and then 
kept in an air-tight bottle in a refrigerator (40C) until used.  
2.3 Experimental design 
An open, randomised controlled design was used for this study. The design was approved by the 
Ethical Committee of College of Veterinary Medicine, Federal University of Agriculture, Abeokuta. 
The dogs were randomly divided into three equal groups. Group A comprised of five dogs in which 
diabetes was neither induced nor treated but were given normal saline. Group B comprised of five 
dogs in which diabetes was induced but were not treated. Group C comprised of five dogs in which 
diabetes was induced and thereafter treated with Moringa oleifera leaves extract (300 mg/kg).  
2.4 Acute toxicity testing 
Three dogs (A, B and C) were subjected to acute toxicity testing by respectively giving 1000mg, 
3000mg and 5000mg of moringa aqueous extract orally to the dogs. The dogs were observed for signs 
of toxicity.    
2.5 Determination of blood glucose level and induction of diabetes mellitus 
Blood was obtained from the animals before fasting through the cephalic vein to determine their non-
fasting blood glucose levels in mg/dl using Accu-Chek Glucometer (Roche, Germany). Food was 
withdrawn from the dogs overnight, and 5% solution of alloxan monohydrate (Sigma, USA) was 
administered intravenously to groups B and C dogs through the cephalic vein at the dose of 80 mg/kg 
body weight. The fasting blood glucose of each dog was then determined at 0, 8, 16, 24 and 48 hours 
after the administration of alloxan monohydrate. 
2.6 Administration of Moringa oleifera extract  
The 51.6g of aqueous extract of Moringa oleifera was made up to 1000ml with distilled water to make 
a 5.2% solution. This was administered orally once daily to group C dogs at the dose of 300mg/kg for 
a period of 42 days. The FBG was measured at 0h, 2h, 4h, 8h, 16h, and 24h. 
2.7 Determination of haematological and biochemical parameters 
Blood was collected from the dogs through cephalic vein before and after induction of 
diabetes, and then day 42 post treatment with aqueous extract of moringa leaves for 
haematology as described by Jain, 1986. Part of the blood was centrifuged for 10 minutes at 
2000 rpm and plasma collected for biochemistry using spectrometric and enzymatic 
colorimetric methods. 
3. Statistical analysis 
Data generated from the study were expressed as mean ± standard error of means. Differences 
between the groups were compared by analysis of variance (ANOVA) and Bonferroni's 
Multiple Comparison Test using Graph pad software.  
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4. Results  
4.1 Fasting blood glucose post induction and post treatment 
There was a decrease in the FBG levels of groups B and C below the pre-induction level at 8 
hours post administration of alloxan monohydrate without significant difference (P < 0.05) 
compared to group A. The FBG after falling below the pre-induction level progressively rose 
up to 48 hours when diabetes was achieved with a significant difference (P < 0.05) between 
the induced and non-induced groups. The clinical signs observed after the administration of 
alloxan monohydrate were nausea, vomiting, diarrhoea and dehydration at 3-8 hours post 
administration of alloxan monohydrate. The elevated levels of the FBG of groups C decreased 
significantly (P < 0.05) at 2h and 8h post treatment with Moringa oleifera extract compared to 
untreated group B dogs. The fasting blood glucose of Moringa extract treated group started 
rising again at 8h. The clinical signs of polyuria and polydipsia persisted in both treated and 
untreated groups post treatment but less severe in treated group C.  
4.2 Acute toxicity determination 
There were no apparent clinical signs of acute toxicity in the 3 dogs at any level of the 
administered doses. 
4.3 Haematological changes 
Pack Cell Volume (PCV), red blood cells and haemoglobin concentration (Hb) decreased 
significantly (p < 0.05) in the diabetic groups B and C post induction compared to group A. 
The white blood cells (WBC) insignificantly increased in diabetic groups post induction and 
post treatment. The platelet count increased in diabetic groups B and C post induction without 
significant difference (P > 0.05) between non-diabetic and diabetic groups. After treatment, 
the platelet count further increased with significant difference (p < 0.05) compared to both 
non-diabetic and diabetic-untreated groups (Table 1). 
4.4 Biochemical changes 
The creatinine, urea, alanine aminotransferase and aspartate aminotransferase levels in 
diabetic groups B and C increased significantly (P < 0.05) compared to non-diabetic group A 
post-induction and then decreased in group C post-treatment with moringa extract. Total 
protein concentration increased significantly (P < 0.05) post-induction in diabetic groups but, 
decreased in group C post-treatment with aqueous moringa extract. Albumin decreased 
significantly post induction and post treatment in both diabetic groups B and C. Alkaline 
phosphatase increased slightly in diabetic groups B and C post induction and post treatment 
(Table 2).  
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Table 1: Some haematological parameters of dogs before and after induction, and after 
administration of Moringa oleifera leaves extract 
 Parameters     A     B     C Reference range  
X PCV (%) 35 ± 1.3 36.0 ± 1.1 35 ± 1.0 35 – 55 
Y PCV (%) 35 ± 0.3a 27.0 ± 2.9b  31.0 ± 1.4b 35 – 55 
Z PCV (%) 32 ± 2.9 a 25.0 ± 2.1b 27.0 ± 0.6b 35 – 55 
X HB (g/dl) 12.76 ± 0.3 12.8 ± 0.6 13.2 ± 0.4 12 – 18 
Y HB (g/dl) 10.77 ± 0.2 a  9.0 ± 1.0b 9.0 ± 1.0b 12 – 18 
Z HB (g/dl) 10.67± 0.9 a  8.7 ± 0.6b  9.0 ± 0.2b 12 – 18 
X WBC X 103(Cm3) 18.23 ± 3.2 18.3 ± 1.4 18.2 ± 2.0 6 – 17 
Y WBC X 103(Cm3) 16.21 ± 3.1 20.2 ± 2.6 16.0 ± 1.2 6 – 17 
Z WBC X 103(Cm3) 16.70± 2.4 20.4 ± 0.7 18.5 ± 2.6  6 – 17 
X RBC X 1012/L 5.52 ± 0.2 5.6 ± 0.1 5.6 ± 0.1  5.5 - 8.5 
Y RBC X 1012/L 5.27 ± 0.1 a 4.2 ± 0.5b 4.9 ± 0.2b 5.5 - 8.5 
Z RBC X 1012/L 5.36 ± 0.4 a  4.0 ± 0.3b 4.2 ± 0.1b 5.5 - 8.5 
X PLAT X 1011/L 6.75 ± 0.2 5.2 ± 0.2 6.4 ± 0.2 2 – 9 
Y PLAT X 1011/L 6.50 ± 0.3  5.9 ± 0.4 6.4 ± 0.2 2 – 9 
Z PLAT X 1011/L 6.51 ± 0.3a 6.0 ± 0.3a 7.0 ± 0.2b 2 – 9 
Key: A= Non-diabetic, B = Diabetic-Untreated, C = Moringa oleifera treated group, PCV = packed cell 
volume, HB = haemoglobin, WBC = white blood cells, RBC = red blood cells, PLAT = platelet, X = basal value, 
Y = post induction of diabetes, Z = post treatment with moringa leaves extract, a, b Values in the same rows with 
different superscripts are significantly different (P < 0.05). 
 
Table 2: Some biochemical parameters of dogs before and after induction, and after 
administration of Moringa oleifera leaves extract 
 Parameters      A      B     C Reference Value 
X T. Pro (g/L) 50.0 ± 1.4 58.1 ± 2.7 53.2 ± 2. 2    55-75 
Y T.Pro (g/L)  47.0 ± 2.5a 59.3 ± 4.0b 70.4 ± 2.2b 
Z T.Pro (g/L)  46.6 ± 1.6a 63.2 ± 1.6b   62.2 ± 2.9b 
X Albumin (g/L) 29.1 ± 3.6  31.0 ± 0.3 31.7 ± 1.9 26-40 
Y Albumin (g/L) 28.8 ± 2.9a 35.1 ± 1.7b 37.5 ± 1.7b 
Z Albumin (g/L) 27.8 ± 1.0a 34.1 ± 1.7b 33.8 ± 0.6b 
X Urea  mg/dl 10.0 ± 1.4 11.5 ± 0.3 12.4 ± 1.9 8.8-26 
Y Urea  mg/dl 9.6 ± 1.4a 23.8 ± 6.6b 22.1 ± 1.2b 
Z Urea  mg/dl 10.1 ± 1.6a 35.8 ± 3.4 b 16.4 ± 1.6c 
X Creat (mg/dl) 0.7 ± 0.0 0.7 ± 0.0 0.7 ± 0.1  0.5-1.6  
Y Creat (mg/dl) 0.7 ± 0.1a  1.4 ± 0.2b 1.4 ± 0.2b 
Z Creat (mg/dl) 1.2 ± 0.2a 1.6 ± 0.1b 0.9 ± 0.1c 
X AST (IU/L) 38.6 ± 5.5 37.5 ± 2.4 37.1 ± 4.2     8.9-49 
Y AST. IU/L 36.9 ± 1.9a 104.6 ± 8.5b 99.3 ± 3.6b 
Z AST. IU/L 38.4 ± 4.1a 97.5 ± 3.2b 55.9 ± 3.3c 
X ALT IU/L 28.4 ± 3.4 20.8 ± 6.9 20.1 ± 3.0  8.2-57 
Y ALT IU/L 30.1 ± 3.7a 73.9 ±12.6b 59.6 ± 4.6b 
Z ALT IU/L 30.1 ± 3.7 a 88.8 ± 5.4b 53.0 ± 3.5c 
X ALP IU/L 35.3 ± 9.8 35.4 ± 5.5 35.0 ± 2.2 10.6-101 
Y ALP IU/L 34.8 ± 8.7 94.7 ± 5.9 85.8 ± 2.3 
Z ALP IU/L 35.6 ± 6.8 92.8 ± 6.7 72.2 ± 6.6 
Key: A= Non-diabetic, B = Diabetic-Untreated, C = Moringa oleifera-Treated, T. Pro = total protein, 
Creat = creatinine, AST = aspartate aminotransferase, ALT = alanine aminotransferase, ALP = 
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alkaline phosphatise, X = baseline value, Y = post induction of diabetes, Z = post treatment with 
moringa leaf extract   
5. Discussion 
The clinical signs of nausea, vomiting, diarrhoea and dehydration observed between 3 and 8 
hours post administration of alloxan monohydrate were due to the adverse effect of the 
chemical. Hypoglycaemia was observed at 8 hours after the intravenous administration of 
alloxan monohydrate. The destruction of beta-cells by alloxan monohydrate trigger the release 
of excess insulin into the vascular system resulting in over utilization of blood glucose. This 
observation was in consonance with that of Kim et al., (2006), was reported hypoglycaemia in 
dogs after induction of diabetes with alloxan monohydrate. The moringa extract decreased the 
fasting blood glucose after 2 hours of administration after which it started rising at 8 hours. 
This showed that it has hypoglycemic effect which can only last for 8 hours. It can be 
suggested that it needs 8 hourly dosing to be able to maintain plasma concentration. Alkaloids 
have been reported to produce hypoglycaemic effect in mice, (Kubo, et al., 2002). Li et al., 
(2000), reported the hypoglycaemic effect of saponins in mice, while, Ojo et al., (2010), 
reported that flavonoids produced hypoglycaemic effect in rats. In this study, the 
hypoglycaemic activity of the leaves of Moringa oleifera may probably be due to the presence 
of the biological principles such as flavonoids, alkaloids, saponins, glycosides (niazirin and 
niaziminin), which are involved in the stimulation of the B-cells and subsequent secretion of 
preformed insulin.  
  The decrease in PCV, RBC and haemoglobin concentration might be due to the 
inflammatory process seen in diabetic condition. The activities of proinflammatory cytokines 
especially, interleukin-6 and tumor necrosis factor alpha have been reported to be contributors 
of anaemia of inflammatory diseases. Tumor necrosis factor (NF-α) contributes to anaemia of 
inflammatory diseases by inhibiting erythropoietin secretion and /or response along with 
direct toxicity on the erythroid precursor cells (Chikazawa and Dunning, 2016), while 
interleukin-6 induces production of hepcidin which binds to ferroportin thereby blocking the 
intestinal absorption of iron (Ganz and Nemeth, 2011). Diabetes mellitus is characterized by 
enhanced platelets activation and coagulation proteins and reduced fibrinolytic activity (Carr, 
2001). In this study, there was increased platelet count in the diabetic groups which 
significantly increased in the moringa treated group. This observation is consistent with the 
report of Oru et al., (2016), who observed significant increase of platelet count in 
streptozotocin-induced diabetic rats, and Hisham et al., (2012) who reported significant 
increase in platelet count in rats and rabbits fed daily with M. oleifera for 21 days. The 
significant increase in platelet count in the moringa treated group portended risk of macro and 
micro cardiovascular complications. Many authors have reported that increased morbidity and 
mortality in type 2 Diabetes mellitus are associated with macro vascular (cardiovascular 
diseases, stroke, and peripheral arterial disease) and micro vascular (nephropathy, neuropathy 
and retinopathy) complications due to platelet dysfunction (Vinik et al, 2001; Ferroni et al., 
2004).  
The increase in levels of both creatinine and urea seen in this study is suggestive of 
kidney damage which could be due to the cytotoxic effect of alloxan monohydrate as reported 
by Valilou et al., (2007) as well as low kidney perfusion as a result of anaemia. The decrease 
in albumin concentration might be due to degenerative changes in the liver. The decrease seen 
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in total protein concentration could have resulted from dehydration.  The activities of ALT 
and AST were high and it indicates hepatocytes damage which must have resulted from the 
inflammatory process in hyperglycaemic conditions. The cytotoxic effect of alloxan chemical 
is another possible means of hepatic damage, and it has been reported by Valilou et al., 
(2007). The decrease in the biochemical parameters in diabetic group C treated with aqueous 
extract of moringa is an indication that apart from having a hypoglycaemic effect, aqueous 
extract of moringa leaves also has an anti-infammatory effect.     
Conclusion   
Moringa oleifera has a hypoglycaemic effect and so can be useful in the management of diabetes 
mellitus in dogs. Plasma creatinine and urea concentrations, Alanine aminotransferase and Aspartate 
aminotransferase activities were elevated in alloxan-induced diabetic dogs and it was decreased by 
aqueous extract of moringa leaves. Platelet count was increased in alloxan-induced diabetic dogs 
treated and remained high after treatment with aqueous extract moringa leaves.   
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